致编辑的信：“头孢他啶-阿维巴坦在血液学患者中的应用：单中心经验” - Suppr

Letter to the editor: "Ceftazidime-avibactam use in hematology patients: single-center experience".

作者信息

Ozdemir Yusuf Emre, Sahin Ozdemir Meryem

机构信息

Department of Infectious Diseases and Clinical Microbiology, Bakirkoy Dr Sadi Konuk Training and Research Hospital, Istanbul, 34140, Turkey.

Department of Infectious Diseases and Clinical Microbiology, Basaksehir Cam & Sakura City Hospital, Istanbul, 34480, Turkey.

出版信息

Eur J Clin Microbiol Infect Dis. 2025 Sep 1. doi: 10.1007/s10096-025-05251-0.

DOI:10.1007/s10096-025-05251-0

PMID:40889069

Abstract

摘要

相似文献

Letter to the editor: "Ceftazidime-avibactam use in hematology patients: single-center experience".

Eur J Clin Microbiol Infect Dis. 2025 Sep 1. doi: 10.1007/s10096-025-05251-0.

Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Organisms: A Prospective, Observational, Single-Center Study.

Antibiotics (Basel). 2025 Jul 31;14(8):773. doi: 10.3390/antibiotics14080773.

evolution of ceftazidime-avibactam resistance in -positive potentially linked to PBP3 insertion and mutations in and PBP2.

JAC Antimicrob Resist. 2025 Aug 1;7(4):dlaf137. doi: 10.1093/jacamr/dlaf137. eCollection 2025 Aug.

The bacterial etiology and antimicrobial susceptibility of lower respiratory tract infections in Vietnam.

Ann Clin Microbiol Antimicrob. 2025 Aug 31;24(1):50. doi: 10.1186/s12941-025-00818-3.

Effectiveness and safety of ceftazidime-avibactam in Chinese patients with hospital-acquired pneumonia, including ventilator-associated pneumonia: A Phase 4, multi-centre, open-label study.

J Glob Antimicrob Resist. 2025 Jun;43:248-255. doi: 10.1016/j.jgar.2025.03.001. Epub 2025 Mar 8.

Molecular mechanisms responsible KPC-135-mediated resistance to ceftazidime-avibactam in ST11-K47 hypervirulent .

Emerg Microbes Infect. 2024 Dec;13(1):2361007. doi: 10.1080/22221751.2024.2361007. Epub 2024 Jun 12.

Impact of ceftazidime-avibactam on mortality in bloodstream infections: a cohort study in patients with acute leukemia.

Ther Adv Infect Dis. 2025 Aug 16;12:20499361251362955. doi: 10.1177/20499361251362955. eCollection 2025 Jan-Dec.

A pre-post quasi-experimental study of antimicrobial stewardship exploring the impact of a multidisciplinary approach aimed at attaining an aggressive joint pharmacokinetic/pharmacodynamic target with ceftazidime/avibactam on treatment outcome of KPC-producing infections and on ceftazidime/avibactam resistance development.

Antimicrob Agents Chemother. 2025 Jul 2;69(7):e0048825. doi: 10.1128/aac.00488-25. Epub 2025 Jun 6.

High-level ceftazidime/avibactam resistance in Escherichia coli conferred by the novel plasmid-mediated β-lactamase CMY-185 variant.

J Antimicrob Chemother. 2023 Oct 3;78(10):2442-2450. doi: 10.1093/jac/dkad249.

Rapid characterization of carbapenem-resistant Enterobacterales by multiplex lateral flow assay and detection of ceftazidime-avibactam-aztreonam synergy.

Indian J Med Microbiol. 2024 Jan-Feb;47:100530. doi: 10.1016/j.ijmmb.2024.100530. Epub 2024 Jan 26.

本文引用的文献

Ceftazidime-avibactam use in hematology patients: single-center experience.

Eur J Clin Microbiol Infect Dis. 2025 Mar 17. doi: 10.1007/s10096-025-05107-7.

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine).

Clin Microbiol Infect. 2022 Apr;28(4):521-547. doi: 10.1016/j.cmi.2021.11.025. Epub 2021 Dec 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Letter to the editor: "Ceftazidime-avibactam use in hematology patients: single-center experience".

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Letter to the editor: "Ceftazidime-avibactam use in hematology patients: single-center experience".

作者信息

机构信息

出版信息

相似文献

本文引用的文献